Mölnlycke®, Health

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Mölnlycke Sweden

en | boerse | 67933093 |